The Food and Drug Administration announced last week that it's investigating reports of secondary cancers in patients who received CAR T-cell therapy, one of a suite of immunotherapies that have revolutionized cancer care ...
Dec 8, 2023
0
0
Even if the patients hadn't been as young as 4 months old, the surgery would have been harrowing: six holes bored into the skull, six tiny tubes inserted directly into targeted parts of the brain, then a solution containing ...
Jan 14, 2013
0
0
A new research paper titled "Aberrant RBMX expression is relevant for cancer prognosis and immunotherapy response" has been published in Aging.
Jan 17, 2024
0
0
By growing new retinal cells to replace those that have malfunctioned, scientists hope to one day create and fuse entire layers of fresh cells –– a synthetic patch akin to a contact lens –– as a treatment for age-related ...
Oct 16, 2012
0
0
Xian-Cheng Jiang, PhD, professor of cell biology at SUNY Downstate Medical Center, has led a study identifying a new approach for lowering "bad" lipids in blood circulation, a critical means to combat devastating cardiovascular ...
Sep 2, 2015
0
6
In biomedical research involving human subjects, research ethics committees around the world have traditionally emphasized individual rights and protections for participants, including informed consent. The emerging field ...
Jul 12, 2024
0
0
A multi-institutional team of researchers have pinpointed the genetic traits of the cells that give rise to gliomas – the most common form of malignant brain cancer. The findings, which appear in the journal Cell Reports, ...
Jun 3, 2013
0
0
Researchers at St. Michael's Hospital are one step closer to understanding why plaque bursts in coronary arteries and causes heart attacks.
Sep 10, 2012
0
0
Scientists at Tulane University School of Medicine, led by Dr. James Antoon and Dr. Barbara Beckman, have characterized two drugs targeting sphingosine kinase (SK), an enzyme involved in cancer growth and metastasis. New ...
Aug 9, 2012
0
0
In the emerging biosimilar market, biosimilar antibodies are being developed to treat conditions currently addressed by their original, targeted biological therapy. Only a few biosimilars are approved by the EMA, and just ...
Apr 16, 2015
0
4
